rSm-p80 + GLA-SE (SchistoShield)

rSm-p80 + GLA-SE · International Vaccine Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rSm-p80 + GLA-SE (SchistoShield), covering 2026-04-29 to 2026-04-29. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the rSm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar [Phase 1]

See pricing